Comparative Safety of Medications for Severe Agitation: Lessons Learned From Management of Behavioral and Psychological Symptoms of Dementia
Authors:
- 31 December 2025
- journal article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 74 (3) , 633-635
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Agitation management strategies for older adults in the emergency department or with emergency medical services: A scoping reviewThe American Journal of Emergency Medicine, 2025
- Safety and effectiveness of benzodiazepines and antipsychotics for agitation in older adults in the emergency departmentThe American Journal of Emergency Medicine, 2023
- Improving the management of acutely agitated patients in the emergency department through implementation of Project BETA (Best Practices in the Evaluation and Treatment of Agitation)JACEP Open, 2020
- The agitated older adult in the emergency department: a narrative review of common causes and management strategiesJACEP Open, 2020
- Managing Delirium and Agitation in the Older Emergency Department Patient: The ADEPT ToolAnnals of Emergency Medicine, 2020
- Assessment of Reported Comparative Effectiveness and Safety of Atypical Antipsychotics in the Treatment of Behavioral and Psychological Symptoms of DementiaJAMA Network Open, 2019
- Trends in Psychotropic Dispensing Among Older Adults with Dementia Living in Long-Term Care Facilities: 2004–2013The American Journal of Geriatric Psychiatry, 2015
- Unintentional Continuation of Medications Intended for Acute Illness After Hospital Discharge: A Population-Based Cohort StudyJournal of General Internal Medicine, 2015
- Antipsychotics, Other Psychotropics, and the Risk of Death in Patients With DementiaJAMA Psychiatry, 2015
- Comparison of Rapidly Acting Intramuscular Olanzapine, Lorazepam, and Placebo A Double-blind, Randomized Study in Acutely Agitated Patients with DementiaNeuropsychopharmacology, 2002